您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

黃英彥醫師

腫瘤學 輻射生物學 生物統計學 放射治療副作用臨床及基礎醫學研究 放射治療效果之轉譯研究 癌症醣蛋白研究 癌症登記資料庫分析 婦癌放射治療 乳癌放射治療 直腸癌放射治療 肺癌放射治療 血液及淋巴腫瘤放射治療 電腦刀立體定位放射治療 質子治療
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚醫院放射腫瘤科教授級主治醫師
    • 台灣放射腫瘤學會理事
    • 台灣癌症登記學會監事
    • 高雄長庚醫院癌症中心主任
  • 學歷
    • 1992中國醫藥大學醫學系畢業
    • 2012長庚大學臨床醫學研究所博士畢業
  • 經歷
    • 1990/6~1991/5:亞東醫院見習醫師
    • 1991/6~1992/6:台大醫院實習醫師(放射腫瘤科實習一個月)
    • 1994/6~1998/6:高雄長庚醫院放射腫瘤科住院醫師
    • 1998/7~2000/6:高雄長庚醫院放射腫瘤科一般級主治醫師
    • 2000/7~2003/6:高雄長庚醫院放射腫瘤科講師級主治醫師
    • 2000/8~ 2003/8:大仁技術學院兼任講師
    • 2003/8~ 2004/2 大仁技術學院兼任助理教授
    • 2003/7~2007/6:高雄長庚醫院放射腫瘤科助理教授級主治醫師
    • 2003/7~2008/12:教育部助理教授
    • 2003/9~ 2004/10 長庚大學醫學系兼任助理教授
    • 2004/11~2008/11: 長庚大學中醫學系專任助理教授
    • 2007/7~2014/6:高雄長庚醫院放射腫瘤科副教授級主治醫師
    • 2008/1~ 實證醫學小組委員
    • 2008/8~2015/1: 教育部副教授
    • 2008/12~2015/1: 長庚大學中醫學系副教授
    • 2009/1~ 動物實驗中心委員
    • 2009/7~2013/9: 高雄長庚醫院放射腫瘤科副主任
    • 2010/1~2015/9: 高雄長庚醫院癌症中心癌症登記負責醫師
    • 2012/9~~2015/9: 台灣癌症登記學會理事
    • 2013/10~: 高雄長庚醫院放射腫瘤科主任
    • 2014/2~: 高雄長庚醫院癌症中心副主任
    • 2014/5~: 台灣放射腫瘤學會理事
    • 2014/7:高雄長庚醫院放射腫瘤科教授級主治醫師
    • 2015/2~: 長庚大學中醫學系暨教育部教授
    • 2015/10~: 台灣癌症登記學會監事
    • 2015/10~: 高雄長庚醫院癌症中心主任
    • 2016/10~: 高雄長庚醫院生物統計中心癌登資料庫統計課程召集人
  • 學會與認證
    • 台灣放射腫瘤學會(TASTRO)
    • 台灣乳房醫學會
    • 台灣癌症登記學會
    • 美國癌症研究學會(AACR)
    • 美國放射腫瘤學會(ASTRO)
    • 歐洲放射腫瘤學會(ESTRO)
    • 中華民國癌症醫學會
    • 台灣醫學教育學會
    • 公職醫師高考及格
    • 放射腫瘤專科醫師
    • 輻射防護師
    • 教育部教授
    • ACLS
  • 論文及期刊發表
    • Results of Postoperative Electron Beam Irradiation for Stage Ⅱ and Ⅲ breast Cancer.
      Therapeutic Radiology and Oncology 1996; 3: 33-40. (學會期刊)
      Huang EY, Leung SW, Wang CJ, Chen HC, Sun LM, Fang FM
    • Treatment of Brain Arteriovenous Malformation (AVM) with Stereotactic Radiosurgery: Preliminary Result in Kaohsiung Chang Gung Memorial Hospital.
      Therapeutic Radiology and Oncology 1999; 6: 89-96.
      Huang EY, Chen HJ, Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Yeh SA, Hsu HC, Hsiung CY, Wu JM, Chen CC.
    • Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial.
      Int J Radiat Oncol Biol Phys 2000;46:535-9. (SCI 4.524)
      Huang EY, Leung SW, Wang CJ, Chen HC, Sun LM, Fang FM, Yeh SA, Hsu HC, Hsiung CY.
    • Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics: evidence for non-dosimetric factors.
      Radiother Oncol 2000;57:91-6. (SCI 4.520)
      Huang EY, Wang CJ, Chen HC, Sun LM, Fang FM, Yeh SA, Hsu HC, Hsiung CY, Wu JM.
    • High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
      Gynecol Oncol 2000;79:406-10. (SCI 3.888)
      Huang EY, Lin H, Hsu HC, Wang CJ, Chen HC, Sun LM, Hsiung CY.
    • Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation.
      Br J Radiol 2002;75:444-7. (SCI 2.366)
      Huang EY, Chen HC, Wang CJ, Sun LM, Hsu HC.
    • Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
      Gynecol Oncol 2004; 95:101-8. (SCI 3.888)
      Huang EY, Wang CJ, Hsu HC, Hao Lin, Chen HC, Sun LM.
    • Acute diarrhea during pelvic irradiation: is small-bowel volume effect different in gynecologic patients with prior abdomen operation or not?
      Gynecol Oncol 2005; 97:118-25. (SCI 3.888)
      Huang EY, Hsu HC, Yang KD, Lin H, Wang FS, Sun LM, Tsai CC, Changchien CC, Wang CJ.
    • The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer.
      Wang CJ; Huang EY*; Hsu HC, Chen HC, Fang FM, Hsiung CY.
      Laryngoscope 2005; 115: 1458-60. (SCI 1.752)
    • Characteristics and predictive factors of early-onset diarrhea during pelvic irradiation.
      Br J Radiol. 2006; 79:419-24. (SCI 1.314)
      Huang EY, Wang CJ, Hsu HC, Sun LM.
    • Multivariate analyses of locoregional recurrences and skin complications following postmastectomy radiotherapy using electrons or photons.
      Int J Radiat Oncol Biol Phys 2006;65:1389-96. (SCI 4.524)
      Huang EY, Chen HC, Sun LM, Fang FM, Hsu HC, Hsiung CY, Huang YJ, Wang CY, Wang CJ.
    • The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry.
      Int J Radiat Oncol Biol Phys. 2007;69:732-9. (SCI 4.524)
      Huang EY, Sung CC, Ko SF, Wang CJ, Yang KD.
    • Treatment Outcome following Three-dimensional Conformal Radiation Therapy (3D-CRT) for NK/T-cell Lymphoma of Nasal Cavity: A Single Institute Survey in Taiwan.
      Therapeutic Radiology and Oncology 2007; 14: 165-78. (學會期刊)
      Wu SU, Fang FM, Kuo CY, Wang CJ, Chen HC, Hsu HC, Huang YJ, Wang CY, Huang EY*.
    • Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of the uterine cervix.
      Int J Radiat Oncol Biol Phys. 2008;72:834-42. (SCI 4.524)
      Huang EY, Wang CJ, Chen HC, Fang FM, Hsu HC, Huang YJ, Wang CY.
    • Aminoguanidine alleviates radiation-induced small-bowel damage through its antioxidant effect.
      Int J Radiat Oncol Biol Phys. 2009;74:237-44. (SCI 4.524)
      Huang EY, Wang FS, Lin IH, Yang KD.
    • Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy (HDR-ICBT) following pelvic irradiation in patients with cervical cancer: A retrospective study with radiography-based dosimetry.
      Int J Radiat Oncol Biol Phys. 2010;76:490-5. (SCI 4.524)
      Huang EY, Wang CJ, Lan RH, Chen HC, Fang FM, Hsu HC, Huang YJ, Wang CY, Wang YM.
    • Effect of non-equal weighting of four fields on small-bowel volume in gynecological patients undergoing whole-pelvic irradiation.
      Therapeutic Radiology and Oncology 2009; 14: 165-78. (學會期刊)
      Liu SY, Chang SC, Chen CF, Sung CC, Fang FM , Juan KJ, Liao TY, Huang EY*.
    • The prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
      Int J Radiat Oncol Biol Phys. 2011; 81: 1105-13. (SCI 4.524)
      Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ*.
    • A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.
      Cell Death Dis. 2012;3:e251. (SCI 6.044)
      Huang EY, Chen YF, Chen YM, Lin IH, Wang CC, Su WH, Chuang PC, Yang KD.
    • Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
      Radiat Oncol. 2012;7(1):13 (SCI 2.321)
      Huang EY*, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.
    • Post-operative low pelvic radiotherapy and chemotherapy for Stage II and III rectal cancer.
      Am J Clin Oncol. 2012;35:68-72. (SCI 2.055)
      Hsu HC, Chen HH, Chang CL, Fang FM, Wang CJ, Chen HC, Huang YJ, Wang CY, Wang YM, Huang EY*.
    • A prospective cohort study to compare treatment results between two fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
      Int J Radiat Oncol Biol Phys. 2013;85:123-8. (SCI 4.524)
      Huang EY, Sun LM, Lin H, Lan JH, Chanchien CC, Huang YJ, Wang CY, Wang CJ*.
    • Effect of different treatment plans on irradiated small-bowel volume in gynecologic patients undergoing whole-pelvic irradiation.
      J Radiat Res 2013;54: 909-18. (SCI 1.447)
      Chang SC, Hsiao-Fei Lee HF, Ting HM, Pan CZ, Liu SY, Chen CF, Wang TY, Juan KJ, Liao TI, Huang EY*.
    • Prognostic factors of radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis.
      J Radiat Res 2013 Jun 27. [Epub ahead of print] (SCI 1.447)
      Wu SU#, Huang EY#*, Chanchien CC, Lin H, Wang CJ, Sun LM, Chen HC, Fang FM, Hsu HC, Huang YJ.
    • Galectin-1 is an independent prognostic factor of local recurrence and survival after definitive radiotherapy for patients with squamous cell carcinoma of the uterine cervix.
      Int J Radiat Oncol Biol Phys. 2013 (in press) (SCI 4.524)
      Huang EY, Chanchien CC, Lin H, Wang CC, Wang CJ, Huang CC*.